Axis Research Scorecard Report - August 2023
We are proud to share that we released several Top Sector Ideas during the month and we highly encourage you to refer to these exclusive reports
309 Views
Sumitomo Pharma (4506 JP): Pain Continues with Dwindling Sales; Trial Setback Worsens Outlook
In Q1FY24, Sumitomo's revenue plummeted 53% YoY to ¥76B. The company reported operating loss of ¥34B. The company’s schizophrenia drug candidate...
361 Views
Axis Top Picks for the month of September 2023
Axis Top Picks basket delivered impressive returns of 28% in the last one year, against the 8% return posted by Nifty 50, beating the benchmark by...
403 Views
Top Sector Ideas - Pharma
In Q1FY24, the Pharma Coverage universe posted robust revenue growth of 20.5%/6.1% YoY/QoQ on account of volume rampup, new launches (especially...
332 Views
Zydus Lifesciences (ZYDUSLIF IN): Strong Start of FY24 Riding on US Formulation Business
Quarterly revenue surpassed INR50B mark for 2nd consecutive quarter. Even upon a high base, US revenue increased 8% sequentially driven by new...
620 Views